How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study

INTRODUCTION: Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria. Its efficacy has been extensively assessed in clinical trials. In routine healthcare settings, however, its effectiveness can be diminished by delayed access to treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Challenger, Joseph D, Gonçalves, Bronner P, Bradley, John, Bruxvoort, Katia, Tiono, Alfred B, Drakeley, Chris, Bousema, Teun, Ghani, Azra C, Okell, Lucy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936434/
https://www.ncbi.nlm.nih.gov/pubmed/31908862
http://dx.doi.org/10.1136/bmjgh-2019-001856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936434/
https://www.ncbi.nlm.nih.gov/pubmed/31908862
http://dx.doi.org/10.1136/bmjgh-2019-001856

Ejemplares similares